ANI Pharmaceuticals (ANIP)

[Just the facts maam]

According to the ANI Q2 earning release

The net loss was $4.6 million for the three months ended June 30, 2013, which included $5.5 million of merger-related expenses.

This equates to $0.9 million in net income, an EPS of approx. $0.09, when you exclude the merger related expenses. If it were trading at quarterly earning multiples of 164 which was the average of the group ANI used for business comparisons. Today's PPS should be approx. $15.46.

Looks like that will only grow on November 7th, as merger related expenses should have been concluded in Q2.